News
-
-
-
-
PRESS RELEASE
Original-Research: CEL-SCI Corporation (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms BUY rating for CEL-SCI Corporation (ISIN: US1508376076) with USD 8.40 price target. Completion of US manufacturing facility for lead drug Multikine expected in H1 2024 -
PRESS RELEASE
BridgeCare Announces $10M Investment to Accelerate Digital Transformation in Early Care and Education System
BridgeCare secures $10 million investment from Avenue Growth Partners to enhance their data and technology infrastructure platform for early care and education, aiming to make the system more equitable and accessible across the U.S -
PRESS RELEASE
Bridechilla Acquisition: Evergreen’s Next Big Step in Wedding Planning Podcasts
Evergreen Podcasts expands Wedding Planning collection with acquisition of Bridechilla, strengthening content library and continuing legacy of excellence. Bridechilla founder Aleisha McCormack's brand to flourish under Evergreen's ownership -
-
-
-
PRESS RELEASE
MWC 2024: Amdocs Unveils CES24, the Telco-Native, Generative AI-led Suite Spanning Business, Operations and Network Domains
Amdocs announces CES24 suite at Mobile World Congress Barcelona, featuring AI-driven assistants to revolutionize service provider businesses with enhanced efficiency, agility, and customer experience